Completed × INDUSTRY × Small Cell Lung Carcinoma × Clear all NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Phase 1/2 Completed
215 enrolled 30 charts
SCLC
Completed
272 enrolled
SKYSCRAPER-02
Phase 3 Completed
490 enrolled 31 charts
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
Phase 1 Completed
21 enrolled
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
Phase 1 Completed
168 enrolled
A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC
Phase 3 Completed
585 enrolled 14 charts
A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants.
Phase 1 Completed
33 enrolled
AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
Phase 1 Completed
23 enrolled 21 charts
Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy
Phase 1/2 Completed
123 enrolled 46 charts
Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC
Phase 2 Completed
107 enrolled 42 charts
A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors
Phase 1 Completed
134 enrolled 37 charts
A Study of AL8326 in Healthy Subjects
Phase 1 Completed
6 enrolled
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Phase 1/2 Completed
145 enrolled 47 charts
KEYNOTE-B99
Phase 2 Completed
126 enrolled
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
Phase 1 Completed
182 enrolled
ARAL
Completed
71 enrolled
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Phase 1/2 Completed
84 enrolled
Trial of NanoPac Intratumoral Injection in Lung Cancer
Phase 2 Completed
18 enrolled 12 charts
LUMINANCE
Phase 3 Completed
152 enrolled 17 charts
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
Phase 1 Completed
41 enrolled
Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer
Phase 3 Completed
457 enrolled 20 charts
RESILIENT
Phase 3 Completed
491 enrolled 24 charts
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma
Phase 1 Completed
188 enrolled
A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjects With Advanced Cancers
Phase 2 Completed
92 enrolled 25 charts
CLOVER
Phase 1 Completed
105 enrolled
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Phase 1/2 Completed
169 enrolled
Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer
Phase 3 Completed
184 enrolled
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
Phase 1/2 Completed
26 enrolled 14 charts
Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer
Phase 1 Completed
29 enrolled
First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours
Phase 1 Completed
60 enrolled
Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250)
Phase 2 Completed
76 enrolled 42 charts
IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer
Phase 1/2 Completed
59 enrolled
Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors
Phase 1 Completed
23 enrolled
Trial of BMS-986012 in Combination With Platinum and Etoposide
Phase 1 Completed
12 enrolled
A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer
Phase 1 Completed
90 enrolled
PASSION
Phase 2 Completed
59 enrolled 17 charts
ESCAPE
Phase 2 Completed
23 enrolled
MAURIS
Phase 3 Completed
155 enrolled
Mass Balance Study of [14C]Chiauranib
Phase NA Completed
6 enrolled
Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)
Phase 2 Completed
66 enrolled
Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients
Phase 3 Completed
95 enrolled 27 charts
DUET-3
Phase 1 Completed
198 enrolled
Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer
Phase 2 Completed
135 enrolled 11 charts
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Phase 1 Completed
12 enrolled 18 charts
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Phase 1/2 Completed
203 enrolled
Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
Phase 2 Completed
730 enrolled 25 charts
A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
Phase 1 Completed
23 enrolled
Safety and Tolerability Evaluation of Low-dose Radiation in Combination With CS1001 in Relapsed SCLC Patients
Phase 1 Completed
11 enrolled
BMS-986012 in Relapsed/Refractory SCLC
Phase 1/2 Completed
106 enrolled 36 charts
A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer
Phase 1 Completed
132 enrolled